Celsion (CLSN) Tripled YTD: Will It New High Soon?

The Celsion Corporation (NASDAQ: CLSN) stock has been one of the major gainers so far this year and it could be time for investors to start looking into the stock.

The Celsion stock has managed to soar as big as threefold over the course of 2021 so far and it is likely that the stock is now on the radars of plenty of investors. One of the important triggers for the rally in the stock came about this past Friday.

Being involved in the oncology medicine development space just let Celcion announce on Friday that it established a Vaccine Advisory Board. In addition to that, Celsion also announced that the first two members have also been added to the board. One of those is Britt A. Glaunsinger, a Virology & Molecular Biology professor at Howard Hughes Medical Institute and the other is Dr. Xinzhen Yang. The latter is the independent professional consultant at the Gerson Lehman Group.

Michael Rowels

Weekend Contributor. Writing for business and finance publishers has become his passion over the last decades after he completed a master's degree in Financial Management. Sharing some opinions and forecasts to thousands of readers is a routine job for him but he never promises to invest in one stock.

Michael Rowels has 964 posts and counting. See all posts by Michael Rowels